| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.5 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |